Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
Diabetic retinopathy is one of the most important causes of blindness. The underlying mechanisms of this disease include inflammatory changes and remodeling processes of the extracellular-matrix (ECM) leading to pericyte and vascular endothelial cell damage that affects the retinal circulation. In t...
Guardado en:
Autores principales: | Ortiz,Gustavo, Salica,Juan P, Chuluyan,Eduardo H, Gallo,Juan E |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2014
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602014000100052 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
por: M. Yu. Pervakova, et al.
Publicado: (2016) -
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
por: Dunlea DM, et al.
Publicado: (2018) -
Construction of an engineered alpha 1-antitrypsin with inhibitory activity based on theoretical studies
por: Sangachini,Elham Dasi, et al.
Publicado: (2012) -
Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria
por: Ning J, et al.
Publicado: (2020) -
Elevating the expression level of biologically active recombinant human alpha 1-antitrypsin in Pichia pastoris
por: Arjmand,Sareh, et al.
Publicado: (2013)